Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx, Astrazeneca, Blueprint, Clene, Gilead, Immunogenx, Novartis, Passage, Plus, Roche, Sanofi, Viridian and Virios.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astrazeneca, Cincor, Cocrystal, Cstone, Daiichi, Eqrx, Hutchmed, Innovent, Karuna, Kodiak, Neuren, Sapience.